Literature DB >> 2558611

In vitro activity of amifloxacin against outer membrane mutants of the family Enterobacteriaceae and frequency of spontaneous resistance.

M Watanabe1, M Inoue, S Mitsuhashi.   

Abstract

Amifloxacin showed potent inhibitory activity against DNA gyrase of Escherichia coli. The difference in the susceptibilities of lipopolysaccharide-deficient Salmonella typhimurium mutants and their parent strain was less than twofold, and the difference in the susceptibilities of porin-deficient E. coli mutants and their parent strain was less than twofold. There was cross resistance among the quinolone group of agents; however, the decrease in MIC for norB mutants was slightly lower than that of other fluoroquinolones. Cell lysis was induced with combined treatment of amifloxacin and sodium dodecyl sulfate in E. coli. The frequency of mutants spontaneously resistant to amifloxacin was extremely low in all species tested.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2558611      PMCID: PMC172773          DOI: 10.1128/AAC.33.11.1837

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  DNA gyrase: purification and catalytic properties of a fragment of gyrase B protein.

Authors:  M Gellert; L M Fisher; M H O'Dea
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

2.  Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme.

Authors:  A Sugino; C L Peebles; K N Kreuzer; N R Cozzarelli
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

3.  Mutation causing reverse osmoregulation of synthesis of OmpF, a major outer membrane protein of Escherichia coli.

Authors:  F Nara; K Inokuchi; S Matsuyama; S Mizushima
Journal:  J Bacteriol       Date:  1984-08       Impact factor: 3.490

4.  Genetic analysis of the ompB locus in Escherichia coli K-12.

Authors:  M N Hall; T J Silhavy
Journal:  J Mol Biol       Date:  1981-09-05       Impact factor: 5.469

5.  Antimicrobial spectrum of Win 49375.

Authors:  N V Jacobus; F P Tally; M Barza
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

6.  Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.

Authors:  M W Hane; T H Wood
Journal:  J Bacteriol       Date:  1969-07       Impact factor: 3.490

7.  Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.

Authors:  C C Sanders; W E Sanders; R V Goering; V Werner
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

8.  Amifloxacin activity against well-defined gentamicin-resistant, gram-negative bacteria.

Authors:  J F John; J A Twitty
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

9.  In vitro and in vivo activity of DL-8280, a new oxazine derivative.

Authors:  K Sato; Y Matsuura; M Inoue; T Une; Y Osada; H Ogawa; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

10.  In vitro and in vivo antibacterial activity of AT-2266.

Authors:  K Kouno; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

View more
  8 in total

1.  In vitro activity of E1040 against imipenem-resistant Pseudomonas aeruginosa strains.

Authors:  M Watanabe; E Inoue; K Katsu; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

2.  A beta-lactamase from Serratia marcescens hydrolyzing the 2-carboxypenam T-5575.

Authors:  N Matsumura; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

Review 3.  Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples.

Authors:  H Nikaido; D G Thanassi
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

4.  In vitro activity of YM133, a new semisynthesized macrolide.

Authors:  T Terasawa; M Watanabe; T Okubo; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

5.  Transferable imipenem resistance in Pseudomonas aeruginosa.

Authors:  M Watanabe; S Iyobe; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

6.  In vitro antibacterial activities of tosufloxacin against and uptake of tosufloxacin by outer membrane mutants of Escherichia coli, Proteus mirabilis, and Salmonella typhimurium.

Authors:  J Mitsuyama; Y Itoh; M Takahata; S Okamoto; T Yasuda
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

Review 7.  Impermeability to quinolones in gram-positive and gram-negative bacteria.

Authors:  L E Bryan; J Bedard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

8.  In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents.

Authors:  N Khardori; H Nguyen; B Rosenbaum; K Rolston; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.